Advances in human disease research, specifically regenerative medicine and precision therapies have resulted from ground-breaking work using in vitro 3D cell models. These advanced cell models have been shown to display structural, morphogenetic and functional properties that resemble in vivo pathophysiology, creating a complex cell model for predictive and translational research. However, to establish and accelerate organoid relevance to clinical outcomes, approaches are required that can reduce variability while also increasing insight. Innovations in culturing ex vivo human models has opened a world of scientific possibilities but are still limited by the technologies used to characterize these complex cell models.
The Incucyte® Organoid Assay addresses the challenges of 3D organoid workflows, through integration of an optimized assay protocol and software solution that enables real time, label-free analysis for efficient, reliable, multiparametric monitoring of organoids in physiologically relevant conditions. Drive organoid insights and the development of novel therapies with ease using the Incucyte® Organoid Analysis Software Module.
Assess relevant data in advanced cell models through temporal, label-free image acquisition and analysis. The Incucyte® Organoid Assay uses an established protocol and purpose-built software, for continuous acquisition and objective analysis of organoid size, count and morphology in a microplate format all from inside your incubator.
Track and standardize the analysis of organoids embedded in Matrigel® over time, to generate reproducible, physiological relevant data without disturbing your cultures.
Locate and Analyze Organoids Automatically
Track organoids embedded in Matrigel® continuously to visualize and assess organoid growth and death
Quantify Organoid Growth / Death using Label-free Analysis
Perform real-time, multiparametric analysis of organoids to better predict therapeutic outcomes using the Incucyte® Organoid Analysis Software Module
Improve Efficiency and Reproducibility
Increase data consistency using an established protocol to reproducibly form organoids in a 96-well microplate format
Figure 1. Kinetically monitor distinct organoid phenotypes using the Incucyte® Live-Cell Analysis System. Mouse intestinal, hepatic and healthy human brain organoids were seeded (50% Matrigel®) into 96-well plates and imaged in an Incucyte®. Brightfield videos taken 3d post seeding and images show cell type specific morphology & growth characteristics.
Figure 2. Perform automated label free quantification of organoids. Mouse intestinal (1:6 split) and hepatic organoids (1K cells/well) were embedded in Matrigel® (50%) in 96-well plates and imaged over 4 - 10 days. Time-lapse videos and corresponding time-courses of brightfield area demonstrate that vehicle treated organoids increase in size over time while Staurosporine exhibits inhibitory effects on organoid growth.
Figure 3. Measure changes in organoid morphological features in response to compound treatment. Brightfield images show hepatic organoids (1K cells/well) ± protein kinase inhibitor Staurosporine (1 µM, STP). Vehicle treated organoids increase in size & number while a marked reduction is observed in the presence of STP. Images (zoomed in) and time-course data also demonstrate that in the presence of STP organoids lose distinctive rounded phenotype (increased eccentricity) and increase in darkness over time.
Figure 5. Easy to use guided interface. Automated image and analysis tools provide a ‘set up and walk away’ experience. Track organoid growth and death in 96-well plates in real time anywhere.